Age (years), mean (SD) |
71 (17) |
Male, n (%) |
183,928 (55) |
Charlson comorbidity index, mean (SD) |
1.4 (1.9) |
Planned or emergency admission, n (%) |
|
Planned admission |
172,754 (51) |
Emergency admission |
164,378 (49) |
Intensive care unit admission, n (%) |
89,316 (26) |
High-care unit admission, n (%) |
55,066 (16) |
Surgery with general anesthesia, n (%) |
88,523 (26) |
Use of antibiotics, n (%) |
314,033 (93) |
Annual hospital volume (patients per year), mean (SD) |
76 (52) |
Underlying disorders, n (%) |
|
Marked bleeding type of DIC |
|
Leukemia |
31,059 (9) |
Trauma |
16,844 (5) |
Obstetric diseases |
16,742 (5) |
Aortic diseases |
9,721 (3) |
Organ failure type of DIC |
|
Sepsis |
140,538 (42) |
Lung |
37,847 (11) |
Abdomen |
41,224 (12) |
Urinary tract |
26,733 (8) |
Central nervous system |
3,274 (1) |
Skin and soft tissues |
4,882 (2) |
Cardiovascular system |
6,429 (2) |
Other infections |
38,090 (11) |
Pancreatitis |
9,052 (3) |
Asymptomatic type of DIC |
|
Solid cancer |
104,323 (31) |
Esophagus |
3,749 (1) |
Stomach |
17,911 (5) |
Colon |
19,816 (6) |
Liver |
9,578 (3) |
Bile duct/gallbladder |
10,188 (3) |
Pancreas |
10,707 (3) |
Lung |
10,816 (3) |
Gynecological |
4,874 (1) |
Urological |
10,981 (3) |
Breast |
2,575 (1) |
Other solid cancers |
12,503 (4) |
Miscellaneous |
8,853 (3) |
Anticoagulants used for DIC, n (%) |
|
Antithrombin |
85,488 (25) |
Recombinant thrombomodulin |
122,224 (36) |
Serine protease inhibitors |
125,344 (37) |
Heparin |
102,048 (30) |
Antifibrinolytics used for DIC, n (%) |
|
Tranexamic acid |
47,408 (14) |
Blood components used for DIC, n (%) |
|
Fresh frozen plasma |
87,098 (26) |
Platelets |
82,959 (25) |
Organ failure score, mean (SD) |
2.0 (1.0) |
Major bleeding events, n (%) |
33,454 (10) |
Outcomes |
|
In-hospital mortality, n (%) |
125,933 (37) |
Length of stay (days), mean (SD) |
41 (83) |
Total hospitalization costs (thousands of USD), mean (SD) |
25 (31) |